$BCRX
BioCryst Pharmaceuticals Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is BCRX up today? It is at $9.99 (+0.71%), and our scanner flagged it 115 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BCRX spikes, and full due diligence on BCRX — key stats, earnings, dilution and insider activity. Free.
Get free $BCRX alerts the moment volume spikes
Our scanner flagged $BCRX 115 times in the last 30 days. Create a free account to track $BCRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $9.99
- Change today
- +0.71%
- Previous close
- $9.92
- 52-week range
- $6.00 – $11.22
- Market cap
- $2.48B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 32.9M ▲ +0% vs prior · as of 2026-08-14
- Days to cover
- 8.0d
- Avg daily volume
- 4.7M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 0.5x
- 15mthin
- 0.5x
- 1hthin
- 0.5x
- 1D
- 0.0x
Get free BCRX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $BCRX up today?
Here is the latest on BCRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying9 buys, 0 sells last 3 months (28/18 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Heggie Theresa Director | Acquired (grant/award) | +15K | added 23% | 81K | n/a | Jun 11, 26 |
Mckee Amy E Director | Acquired (grant/award) | +15K | added 48% | 47K | n/a | Jun 11, 26 |
Stonehouse Jon P Director | Acquired (grant/award) | +15K | added 1.2% | 1.34M | n/a | Jun 11, 26 |
Milano Vincent Director | Acquired (grant/award) | +15K | added 16% | 108K | n/a | Jun 11, 26 |
Sanders Machelle Director | Acquired (grant/award) | +15K | added 50% | 46K | n/a | Jun 11, 26 |
Frank Steven Director | Acquired (grant/award) | +15K | added 76% | 35K | n/a | Jun 11, 26 |
Levin Alan G Director | Acquired (grant/award) | +15K | added 24% | 80K | n/a | Jun 11, 26 |
Galson Steven K Director | Acquired (grant/award) | +15K | added 100% | 28K | n/a | Jun 11, 26 |
Milne Jill C. Director | Acquired (grant/award) | +15K | added 92% | 32K | n/a | Jun 11, 26 |
Frank Steven Director | Acquired (grant/award) | +1K | added 6.7% | 20K | $11K at $8.91 | May 29, 26 |
Milano Vincent Director | Acquired (grant/award) | +1K | added 1.2% | 93K | $10K at $8.91 | May 29, 26 |
Mckee Amy E Director | Acquired (grant/award) | +631 | added 2.0% | 32K | $6K at $8.91 | May 29, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $BCRX. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$BCRX Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$BCRX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to BCRX
Comparable names in biological products, (no diagnostic substances), closest in size first.
BCRX stock FAQ
Why is $BCRX up today?
Here is the latest on BCRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the BCRX stock price today?
BCRX last traded at $9.99, up 0.71% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live BCRX alerts?
The BCRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BCRX 115 times in the last 30 days.
What exchange is BCRX on?
BCRX (BioCryst Pharmaceuticals Inc) trades on XNAS, with a market cap of about $2.48B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is BCRX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BCRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.